To unravel potential sources for systemic EndMT markers, we determined tissue expression of S100A4 and EGFR in iPAH lungs and endarterectomized tissues obtained from CTEPH patients. This evidence concerns the gene S100A4 and chronic thromboembolic pulmonary hypertension.